Coagulation Factor X
F10proteinActivated Factor X catalyzes prothrombin conversion to thrombin, a central step in occlusive coronary thrombus formation.
Pathway placement
Cascade stepCoagulation & thrombus formation
Confidencehigh
RationaleActivated Factor X (prothrombinase complex component) drives thrombin generation.
Also acts inPlatelet activation
Druggability
DruggableYes
Known drugs / candidates16
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000126218
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I66
C — confounder / Type-II67
A — assay feasibility72
E — evidence strength28
T1DI (composite)10
Specificity differential (R−C)-1.4
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Human genetic evidence
0.259
Open Targets association (STEMI)
Literature evidence(5)
- Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration.Journal of thrombosis and haemostasis : JTH · 2024 · PMID 39551435 · doi
- Quantitative proteomics reveals differential immunoglobulin-associated proteome (IgAP) in patients of acute myocardial infarction and chronic coronary syndromes.Journal of proteomics · 2021 · PMID 34890869 · doi
- Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.Journal of biological regulators and homeostatic agents · 2004 · PMID 15471223
- Platelet-dependent and procoagulant mechanisms in arterial thrombosis.International journal of cardiology · 1999 · PMID 10328604 · doi
- Rebound after cessation of oral anticoagulant therapy: the biochemical evidence.British journal of haematology · 1996 · PMID 8603020 · doi